IHE icon

iShares US Pharmaceuticals ETF
IHE

Overview Fund Activity

92 hedge funds and large institutions have $83.8M invested in iShares US Pharmaceuticals ETF in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 11 closing their positions.

Holders
92
Holders Change
-1
Holders Change %
-1.08%
% of All Funds
1.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
29
Reduced
24
Closed
11
Calls
$1.55M
Puts
$525K
Net Calls
+$1.03M
Net Calls Change
+$685K

Top Buyers

1
Royal Bank of Canada
1
Royal Bank of Canada
Ontario, Canada
$9.33M
2
Citadel Advisors
2
Citadel Advisors
Florida
$7.11M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$6.11M
4
TRCT
4
Tower Research Capital (TRC)
New York
$1.31M
5
SPIA
5
Steward Partners Investment Advisory
New York
$2.37M

Top Sellers

1
Fisher Asset Management
1
Fisher Asset Management
Washington
$863K
2
Jane Street
2
Jane Street
New York
$0
3
SRSA
3
S.R. Schill & Associates
Washington
$990K
4
ST
4
Spinnaker Trust
Maine
$1.2M
5
Wells Fargo
5
Wells Fargo
California
$1.67M
Name Market Value Shares Shares
Change 		Shares
Change %
EWM
101
EPG Wealth Management
Georgia
– – -309 Closed
NFG
102
Next Financial Group
Texas
– – -168 Closed
MWM
103
MBE Wealth Management
Wisconsin
– – -54 Closed
HNB
104
Huntington National Bank
Ohio
– – – –
RFA
105
Reilly Financial Advisors
California
– – – –
1 2 3 4
5